DR. PATRICK M TRAVIS M.D. NPI 1104897099

NPI Details

DR. Patrick M Travis, M.D. is a hematology and oncology internal medicine in Fayetteville, AR with 36 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Patrick M Travis, M.D. NPI is 1104897099. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Graduation Year:1990

The provider's business location address is:

3232 N NORTHHILLS BLVD
FAYETTEVILLE, AR
ZIP 72703-005
Phone: (479) 587-1700
Fax: (479) 587-1366

The NPI 1104897099 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, carfilzomib, 1 mg (HCPCS:J9047)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Uric acid level, blood (HCPCS:84550)
• Bilirubin level, direct (HCPCS:82248)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Iron binding capacity (HCPCS:83550)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Blood test, clotting time (HCPCS:85610)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Unclassified drugs (HCPCS:J3490)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Ct scan of chest with contrast (HCPCS:71260)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Vitamin d-3 level (HCPCS:82306)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of influenza virus vaccine (HCPCS:G0008)
• X-ray of chest, 2 views (HCPCS:71046)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Blood creatinine level (HCPCS:82565)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Ct scan of chest without contrast (HCPCS:71250)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Mri scan of lower spinal canal before and after contrast (HCPCS:72158)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Drawing of blood for a medical problem (HCPCS:99195)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Mri scan of middle spinal canal before and after contrast (HCPCS:72157)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Mri scan of pelvis before and after contrast (HCPCS:72197)
• Ct scan of blood vessels of chest with contrast (HCPCS:71275)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Ct scan of face before and after contrast (HCPCS:70488)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Mri scan of leg joint before and after contrast (HCPCS:73723)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• Heart muscle strain imaging (HCPCS:93356)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)

The enumeration date for this NPI number is 1/30/2006 and was last updated on 3/30/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.